Skandinaviska Enskilda Banken AB publ Has $19.81 Million Stake in CME Group Inc. $CME

Skandinaviska Enskilda Banken AB publ lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 3.9% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 73,268 shares of the financial services provider’s stock after selling 2,971 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in CME Group were worth $19,806,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in CME. Empowered Funds LLC raised its holdings in CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after acquiring an additional 1,037 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of CME Group by 2.1% in the second quarter. Nordea Investment Management AB now owns 32,575 shares of the financial services provider’s stock valued at $8,899,000 after purchasing an additional 655 shares in the last quarter. Signature Estate & Investment Advisors LLC lifted its position in CME Group by 5.8% in the second quarter. Signature Estate & Investment Advisors LLC now owns 1,618 shares of the financial services provider’s stock worth $446,000 after purchasing an additional 89 shares during the period. International Assets Investment Management LLC boosted its stake in CME Group by 3.3% during the second quarter. International Assets Investment Management LLC now owns 2,364 shares of the financial services provider’s stock worth $652,000 after buying an additional 76 shares in the last quarter. Finally, Evermay Wealth Management LLC increased its holdings in CME Group by 14.3% in the 2nd quarter. Evermay Wealth Management LLC now owns 400 shares of the financial services provider’s stock valued at $110,000 after buying an additional 50 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Up 0.1%

Shares of CME opened at $303.23 on Wednesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The company has a market cap of $109.34 billion, a price-to-earnings ratio of 27.17, a PEG ratio of 3.29 and a beta of 0.27. The stock has a fifty day moving average price of $281.14 and a two-hundred day moving average price of $274.30. CME Group Inc. has a 52-week low of $244.43 and a 52-week high of $309.35.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the business earned $2.52 earnings per share. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. Analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be paid a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s payout ratio is presently 46.59%.

Insiders Place Their Bets

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Dennis Suskind sold 748 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the transaction, the director owned 2,699 shares in the company, valued at $809,700. The trade was a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on CME shares. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Rothschild & Co Redburn raised their price target on shares of CME Group from $300.00 to $333.00 and gave the stock a “neutral” rating in a research note on Thursday, February 12th. Morgan Stanley upped their price objective on CME Group from $319.00 to $340.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. The Goldman Sachs Group increased their target price on CME Group from $264.00 to $266.00 and gave the stock a “sell” rating in a report on Monday, February 9th. Finally, Piper Sandler boosted their price target on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus price target of $299.53.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.